Cabazitaxel for metastatic castration-resistant prostate cancer: Safety data from the Spanish expanded access program

dc.contributor.author	Antón Aparicio, Luis Miguel
dc.date.accessioned	2017-06-07T07:36:14Z
dc.date.available	2017-06-07T07:36:14Z
dc.date.issued	2014
dc.identifier.issn	1474-0338
dc.identifier.uri	http://hdl.handle.net/20.500.11940/8422
dc.language.iso	eng
dc.title	Cabazitaxel for metastatic castration-resistant prostate cancer: Safety data from the Spanish expanded access program
dc.type	Artigo	es
dc.authorsophos	Castellano, D.
dc.authorsophos	Antón Aparicio, L. M.
dc.authorsophos	Esteban, E.
dc.authorsophos	Sánchez-Hernández, A.
dc.authorsophos	Germà, J. R.
dc.authorsophos	Batista, N.
dc.authorsophos	Maroto, P.
dc.authorsophos	Pérez-Valderrama, B.
dc.authorsophos	Luque, R.
dc.authorsophos	Méndez-Vidal, M. J.
dc.identifier.sophos	15252
dc.issue.number	9
dc.journal.title	Expert Opinion On Drug Safety
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña::Oncoloxía médica
dc.page.initial	1165
dc.page.final	1173
dc.rights.accessRights	openAccess
dc.typesophos	Artículo Original
dc.volume.number	13

Files in this item

Files	Size	Format	View
There are no files associated with this item.